Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Opsoclonus myoclonus syndrome Stories

2012-07-23 02:24:50

SAN DIEGO, July 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announced data from an interim analysis of two randomized Phase III clinical trials, HNBE-01 and HNBE-02, using electrochemotherapy to treat locally recurrent and second primary squamous cell carcinoma of the head and neck (SCCHN). The data are being presented July 22-24 at the 8th International...

2012-06-21 23:01:43

On June 23, 2012, the Matthew Bittker Foundation will present the Children´s Hospital of Michigan Foundation (CHM Foundation) with a check for $50,000 to advance the research and treatment for children diagnosed and/or treated with neuroblastoma at the DMC Children´s Hospital of Michigan. Detroit, Michigan (PRWEB) June 21, 2012 On June 23, 2012, the Matthew Bittker Foundation will present the Children´s Hospital of Michigan Foundation (CHM Foundation) with a check for $50,000...

2012-05-29 02:26:09

SAN DIEGO, May 29, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, issued the following letter to Shareholders today: (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) Dear Shareholder: As we near the mid-point of 2012, OncoSec is successfully executing on its objectives for the year. I want to review the key developments so you can see why all...

2012-05-23 06:24:14

CHICAGO, May 23, 2012 /PRNewswire/ -- The Children's Neuroblastoma Cancer Foundation (CNCF), a nonprofit dedicated to raising awareness and money to fund a cure for neuroblastoma, a pediatric cancer, is country music star Taylor Swift's charity of choice for the 2012 CMT Music Awards June 6 in Nashville. The fan-voted show honors the year's top country videos and musical achievements. (Vote at http://www.cmt.com/cmt-music-awards/categories.jhtml.) CMT will make a donation on...

2012-05-16 14:22:19

PHILADELPHIA, May 16, 2012 /PRNewswire/ -- A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma. To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial (Photo:...

2012-03-14 11:49:00

St. Jude Children's Research Hospital — Washington University Pediatric Cancer Genome Project and Memorial Sloan-Kettering Cancer Center discover first gene alteration associated with patient age and neuroblastoma outcome Researchers have identified the first gene mutation associated with a chronic and often fatal form of neuroblastoma that typically strikes adolescents and young adults. The finding provides the first clue about the genetic basis of the long-recognized but poorly...

2012-03-13 22:34:15

Certain mutations of the gene ATRX were associated with age at diagnosis in children and young adults with advanced-stage neuroblastoma, a cancer that grows in parts of the nervous system, according to a study in the March 14 issue of JAMA. Neuroblastoma is the most common extracranial (outside the cranium) solid tumor of childhood and accounts for 15 percent of all cancer-related deaths in children. "Half of the patients (50 percent) with neuroblastoma present with metastatic disease;...

2011-09-19 23:49:08

Poorer treatment outcomes Patients with a high degree of African ancestry had a greater incidence of high-risk neuroblastoma and poorer outcomes, according to preliminary results presented here at the Fourth AACR Conference on The Science of Cancer Health Disparities, held here Sept. 18-21, 2011. "There are common genetic variants that are associated with the development of high-risk neuroblastoma and a poor outcome," said Navin R. Pinto, M.D., instructor of pediatrics at the University...

2011-06-08 15:51:00

PHILADELPHIA, June 8, 2011 /PRNewswire-USNewswire/ -- Soupy for Loopy Foundation donated $50,000 to the Cancer Center at The Children's Hospital of Philadelphia to fund research in neuroblastoma, a childhood cancer of the nervous system. The $50,000 gift will support two research projects aimed at developing more effective radiation treatments to kill neuroblastoma cells. The treatments, abbreviated as I-MIBG and MABG, selectively attack neuroblastoma tumors while minimizing injury to...

2010-11-29 07:56:13

(Ivanhoe Newswire) -- Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy, with an annual incidence of about 650 new cases per year in the United States.  Close to 50 percent of neuroblastoma cases occur in children younger than two years old.  A recent study has revealed that African American, Asian, and Native American children are more likely than Caucasian and Hispanic children to die after being treated for...